Celcuity Inc. (CELC)
Health Care ยท Services-Medical Laboratories
Celcuity Inc. (CELC) is listed on Nasdaq, where its shares have traded since September 20, 2017. SentiSense covers Celcuity Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Medical Laboratories. Brian Sullivan is its chief executive officer. The company reports 155 employees, and its corporate website is www.celcuity.com.
About Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors. Its candidate, gedatolisib, is a kinase inhibitor of the PI3K/AKT/mTOR (PAM) pathway, binding all class I PI3K isoforms and mTORC1/2, offering comprehensive inhibition with a mechanism and pharmacokinetics differentiated from other therapies. The Phase 3 VIKTORIA-1 trial, evaluating gedatolisib with fulvestrant, with or without palbociclib, in HR+/HER2- breast cancer, has completed enrollment and reported results for PIK3CA WT tumors, with cohort 2 (PIK3CA MT) also enrolled. Phase 3 VIKTORIA-2 and Phase 1b/2 CELC-G-201 trials, evaluating combinations in endocrine-resistant HR+/HER2- breast cancer and metastatic castration-resistant prostate cancer, are ongoing.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 263 institutions reported holding CELC, with 56.6 million shares worth $5.9 billion in aggregate. The largest reported holders were Baker Bros. Advisors, Avoro Capital Advisors and Rtw Investments. Of the 5 largest reported holders, 4 added shares and 1 held its position unchanged during the quarter.
More on CELC
- CELC sentiment: whether news and social coverage of Celcuity Inc. leans bullish or bearish, and the stories driving it.
- CELC ownership: all 263 reporting institutions, plus insider and congressional trades.
- CELC financials: revenue, net income, operating margin and free cash flow by quarter and year.
SentiSense also tracks daily options readings for Celcuity Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Celcuity Inc. do?
Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors.
What sector is CELC in?
SentiSense classifies Celcuity Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Medical Laboratories.
Where does CELC stock trade?
Celcuity Inc. (CELC) is listed on Nasdaq, where its shares have traded since September 20, 2017.
Who is the CEO of Celcuity Inc.?
Brian Sullivan is the chief executive officer of Celcuity Inc..